Mhaka et al., 2004 - Google Patents
Use of methotrexate-based peptide substrates to characterize the substrate specificity of prostate-specific membrane antigen (PSMA)Mhaka et al., 2004
View PDF- Document ID
- 13697574523628658325
- Author
- Mhaka A
- Gady A
- Rosen D
- Lo K
- Gillies S
- Denmeade S
- Publication year
- Publication venue
- Cancer biology & therapy
External Links
Snippet
Prostate-Specific Membrane Antigen (PSMA) is a glutamate carboxypeptidase II that is highly expressed by both normal and malignant prostate epithelial cells and by the neovasculature of many tumor types but is not expressed by endothelial cells in normal …
- 102100008453 FOLH1 0 title abstract description 189
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mhaka et al. | Use of methotrexate-based peptide substrates to characterize the substrate specificity of prostate-specific membrane antigen (PSMA) | |
| Aggarwal et al. | A dimeric peptide that binds selectively to prostate-specific membrane antigen and inhibits its enzymatic activity | |
| JP4541693B2 (en) | CD10-activated prodrug compound | |
| Mizushige et al. | Characterization of Tyr‐Leu‐Gly, a novel anxiolytic‐like peptide released from bovine αS‐casein | |
| Papandreou et al. | Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progression | |
| ES2607935T3 (en) | Antidotes for factor Xa inhibitors and procedures for their use | |
| US8450280B2 (en) | Activation of peptide prodrugs by hK2 | |
| Hekim et al. | Novel peptide inhibitors of human kallikrein 2 | |
| Siegel et al. | Structure-based design of α-amido aldehyde containing gluten peptide analogues as modulators of HLA-DQ2 and transglutaminase 2 | |
| Hargrove et al. | The structure of tyrosine aminotransferase: evidence for domains involved in catalysis and enzyme turnover | |
| Molinaro et al. | Human recombinant membrane-bound aminopeptidase P: production of a soluble form and characterization using novel, internally quenched fluorescent substrates | |
| Deddish et al. | Differences in the hydrolysis of enkephalin congeners by the two domains of angiotensin converting enzyme | |
| CN114341154A (en) | Substrates for tryptase activity assays | |
| Kong et al. | Site-directed mutagenesis of amino acid residues involved in the glutathione binding of human glutathione S-transferase P1-1 | |
| US7906477B2 (en) | Activation of peptide prodrugs by hK2 | |
| AU2005334458A1 (en) | Furin inhibitors | |
| Szepessy et al. | Inactivity of recombinant ELA2B provides a new example of evolutionary elastase silencing in humans | |
| Dahan et al. | Dipeptidyl peptidase IV as a potential target for selective prodrug activation and chemotherapeutic action in cancers | |
| Pakkala et al. | Mimetics of the disulfide bridge between the N-and C-terminal cysteines of the KLK3-stimulating peptide B-2 | |
| Yajima et al. | A rapid anterograde axonal transport of carboxypeptidase H in rat sciatic nerves | |
| XING et al. | Design of a transferrin–proteinase inhibitor conjugate to probe for active cysteine proteinases in endosomes | |
| Petrova-Skalkova et al. | A latent form of cathepsin B in pleural effusions: I. Characterization of the enzyme in breast cancer patients | |
| Jia et al. | USP25-mediated talin-1 stabilization in platelets: a novel mechanism of hyperreactivity and thrombosis risk during aging | |
| PT1238283E (en) | Protease-activated receptor (par) modulator assays | |
| TWI252234B (en) | Novel chromogenic substrates and their use in assaying carboxypeptidase activity |